Twelfth Starr Cancer Consortium Grant Competition

  • APOBEC Mutagenesis in Bladder Cancer: Mechanisms and Therapeutic Opportunities
    Principal Investigator:

    • Bishoy Morris Faltas, MD - Weill Cornell Medicine

     Co-Principal Investigators:

    • John Maciejowski, PhD - Memorial Sloan Kettering Cancer Center
    • Eliezer M. Van Allen, MD - The Broad Institute of MIT and Harvard
    Abstract 
  • Defining prostate cancer cells of origin through single cell profiling
    Principal Investigator:

    • Charles Sawyers, MD - Memorial Sloan Kettering Cancer Center
    Co-Principal Investigator:

    • Orit Rozenblatt-Rosen, PhD - The Broad Institute of MIT and Harvard
    Abstract 
  • Genomic instability in the chromosomal context of physiological DNA double-strand break formation
    Principal Investigator:
    • Jessica Tyler, PhD - Weill Cornell Medicine
    Co-Principal Investigators:

    • Scott Keeney, PhD - Memorial Sloan Kettering Cancer Center
    • Jayanta Chaudhuri, PhD - Memorial Sloan Kettering Cancer Center
    • Barry Sleckman, MD, PhD - Weill Cornell Medicine
    • Marcin Imielinski, MD, PhD - Weill Cornell Medicine
    Abstract 
  • Identification of transcriptional determinants of asparaginase sensitivity in leukemias

    Principal Investigator:

    • Kivanc Birsoy, PhD - The Rockefeller University
    Co-Principal Investigators:

    • Omar Abdel-Wahab, MD - Memorial Sloan Kettering Cancer Center
    • Robert G Roeder, PhD - The Rockefeller University
    • Giorgio Inghirami, MD - Weill Cornell Medicine
    Abstract 
  • Real-time imaging of metabolite deregulation in cancer

    Principal Investigator:

    • Samie R. Jaffrey, MD, PhD - Weill Cornell Medicine

    Co-Principal Investigator:

    • Lydia Finley, PhD - Memorial Sloan Kettering Cancer Center
    Abstract 
  • Lynch syndrome Colorectal Cancer Immunoprevention using Recurrent Neoantigen Peptide Vaccination

    Principal Investigator:

    • Steven Lipkin, MD, PhD - Weill Cornell Medicine

    Co-Principal Investigators:

    • Gad Getz, PhD - The Broad Institute of MIT and Harvard
    • Catherine Wu, MD - The Broad Institute of MIT and Harvard
    • Zsofia Stadler, MD - Memorial Sloan Kettering Cancer Center
    • Nir Hacohen, PhD - The Broad Institute of MIT and Harvard
    Abstract 
  • Using morphological pharmacodynamic markers to analyze drug sensitivity, resistance, and toxicity

    Principal Investigator:

    • Tarun M. Kapoor, PhD - The Rockefeller University
    Co-Principal Investigator:

    • Anne E. Carpenter, PhD - The Broad Institute of MIT and Harvard
    Abstract 
  • The function and regulation of MiT/TFE activation in autophagy and pancreatic ductal adenocarcinoma

    Principal Investigator:

    • Yi-Chieh Nancy Du, PhD - Weill Cornell Medicine

    Co-Principal Investigators:

    • Yueming Li, PhD - Memorial Sloan Kettering Cancer Center
    • Xuejun Jiang, PhD - Memorial Sloan Kettering Cancer Center
    Abstract 
  • Imaging and targeting glycolytically driven oxidative stress using ascorbate

    Principal Investigator:

    • Kayvan R. Keshari, PhD - Memorial Sloan Kettering Cancer Center
    Co-Principal Investigators:

    • Lewis C. Cantley, PhD - Weill Cornell Medicine
    • Manish Shah, MD - Weill Cornell Medicine
    Abstract